Literature DB >> 31051092

Hypersensitivity Pneumonitis Mortality by Industry and Occupation.

Noemi B Hall1, John M Wood1, A Scott Laney1, David J Blackley1.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31051092      PMCID: PMC6701034          DOI: 10.1164/rccm.201904-0810LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
To the Editor: We read with interest the research letter by Fernández Pérez and colleagues (1) and agree that population-level mortality from hypersensitivity pneumonitis (HP) has not been well characterized in the United States. However, the role of occupation in the development and severity of HP is well established (2–4). Occupational exposures are responsible for a substantial portion of HP cases, and it is important to monitor trends in morbidity and mortality so that prevention activities can be prioritized. To that end, we conducted a similar analysis of HP mortality data from 2003 to 2017 (ICD-10 code J67.x) while also taking available employment history into account. We identified a similar demographic risk profile: 58% of decedents were male, 93% were white, and a high proportion lived in the Midwest or Northeast. Using data obtained from 21 states during 2003, 2004, and 2007–2013, we calculated proportionate mortality ratios (PMRs) by usual industry and occupation while adjusting for age, sex, and race. Among industries, the PMR was highest for animal production (PMR, 9.9; 95% confidence interval [CI], 5.1–17.3) and crop production (PMR, 5.2; 95% CI, 2.9–8.7), and among occupations, it was highest among farmers and ranchers (PMR, 7.9; 95% CI, 5.0–11.8). Fernández Pérez and colleagues acknowledge that exposure information was not available in these data; however, because HP is often caused by workplace exposures, a decedent’s work history is a significant factor that should be considered. The authors suggest that genetic differences among racial groups could play a role in determining susceptibility to HP. We think it is unlikely that the racial differences observed are the result of genetic factors. It is far more likely that this observation is confounded by associations with geographical clustering of agricultural industries and occupations that are associated with race, which are in turn associated with exposure to antigens primarily found in organic substances. We applaud the authors for highlighting the public health importance of HP, especially because mortality has been increasing and the root cause of this increase is unknown. Collecting a thorough clinical and occupational history is key to diagnosing HP and identifying an inciting antigen. If an occupational cause is identified, the individual worker might benefit from exposure reduction or avoidance, and a workplace evaluation could be conducted to identify additional cases and assess exposure controls.
  3 in total

1.  Twenty-three years of hypersensitivity pneumonitis mortality surveillance in the United States.

Authors:  Ki Moon Bang; David N Weissman; Germania A Pinheiro; Vinicius C S Antao; John M Wood; Girija Syamlal
Journal:  Am J Ind Med       Date:  2006-12       Impact factor: 2.214

Review 2.  Occupational hypersensitivity pneumonitis: an EAACI position paper.

Authors:  S Quirce; O Vandenplas; P Campo; M J Cruz; F de Blay; D Koschel; G Moscato; G Pala; M Raulf; J Sastre; A Siracusa; S M Tarlo; J Walusiak-Skorupa; Y Cormier
Journal:  Allergy       Date:  2016-03-11       Impact factor: 13.146

3.  Increasing Hypersensitivity Pneumonitis-related Mortality in the United States from 1988 to 2016.

Authors:  Evans R Fernández Pérez; David B Sprunger; Pailin Ratanawatkul; Lisa A Maier; Tristan J Huie; Jeffrey J Swigris; Joshua J Solomon; Michael P Mohning; Rebecca C Keith; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

  3 in total
  1 in total

Review 1.  Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.

Authors:  Teng Moua; Tananchai Petnak; Antonios Charokopos; Misbah Baqir; Jay H Ryu
Journal:  J Clin Med       Date:  2022-03-08       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.